The blastocyst grading system. Modified from Gardner and Schoolcraft.
The preimplantation period of human embryo development is remarkable and characterized by successive changes in terms of genetic control, physiology, and morphology of the embryo. Human preimplantation embryo development is characterized by the initial phase of embryo development, the phase before the embryo implantation process. In normal conditions, after fertilization, the embryo grows until the blastocyst stage. The blastocyst grows as the cells divide and the cavity expands, where it “hatches” from the zona pellucida to implant into the endometrium. Reprogramming and programming are continuous processes in the embryo that encompasses fusion of the egg and sperm pronuclei; epigenetic reprogramming and modification, an extensive wave of degradation of maternal transcripts, and activation of the nascent human embryonic genome and aneuploidy can occur in this stage. The embryo produces cytokines, growth factors, and receptors for endometrial signals in the apposition stage.
Preimplantation embryo development is characterized by a series of events after fertilization including the formation of the maternal and paternal pronuclei, followed by the formation of the zygote, which at ±20 hours after insemination starts undergoing mitotic divisions every 12–18 hours (cleavage stage), reaching the morula (compaction), and the blastocyst grows as the cells divide and the cavity expands, until it arrives at the uterus, where it “hatches” from the zona pellucida to implant into the endometrium. The main objective of blastocyst culture was to increase the success rate of in vitro fertilization (IVF) because of better embryo selection. Blastocyst culture has also been used as a tool to select the most viable embryos in a cohort with a consequent reduction in the number of embryos transferred and the corresponding reduction in the incidence of multiple gestations. This chapter will review about human blastocyst formation and development and discuss about the physiology, morphology, and gene expression of the blastocyst.
2. Physiology of the blastocyst
The transformation of the fertilized oocyte into the blastocyst is not only characterized by major morphological events but also by dramatic changes in its physiology, reflected in changes in the relative activity of the metabolic pathways which provide not only energy but also the biosynthetic intermediates required to support proliferation . The ability of the cleavage stage embryo to react in the environment during early cleavage is limited because the human genome embryo is still inactive and the system that regulates the balance of the osmotic pressure is not fully functional [1, 2].
The tendency of metabolism to produce energy from pronucleate oocytes until blastocyst stage can be assessed from mitochondrial forms. In the stage of pronucleate oocytes and cleavage stage, their mitochondrial form is still immature, and the production of energy in oocytes is usually low and will be increased tremendously from cleavage stage embryo until blastocyst stage. In the stage of pronucleate oocytes, the type of metabolism is oxidative phosphorylation (OXPHOST); then in the cleavage stage embryo, the metabolism uses lactate, pyruvate, specific amino acids, and fatty acids [1, 2, 3].
In the blastocyst stage, the metabolism produces energy that mainly depends on the process of glycolysis, with anabolic dominantly seen in the mitochondria [3, 4].
In the cleavage stage embryo, pyruvate uptake increases continuously until the blastocyst stage. In the blastocyst stage, glucose uptake is higher than pyruvate uptake, and O2 consumption will increase in the initial development stage before compaction (pre-compaction). In the pre-compaction stage, we can observe low biosynthetic activity, low O2 consumption, and ovoid form of mitochondria; the main nutrition is pyruvate, with dominant maternal genome where cells divide in the similar shape [1, 2, 3].
In the post-compaction stage, we can observe high biosynthetic activity, higher oxygen consumption, and elongated form of mitochondria; the main nutrition is glucose, and with dominant human embryo genome. In this stage, cells will be differentiated into trophectoderm (TE) and inner cell mass (ICM) [1, 2, 3, 5].
Amino acids in the metabolism of blastocyst can be used as a source of energy, and some amino acids such as aspartate through malate aspartate shuttle enter in the tricarboxylic acid (TCA) cycle to produce energy. However, glutamine can also enter as glutamate in the TCA cycle to produce energy. Amino acid in the blastocyst stage also plays a role in the regulation of intracellular pH buffer, as a material development process and as antioxidants and chelators [1, 2, 3, 5].
After compaction, the embryo exhibits increased of O2 consumption and glucose usage capacity as an energy source. This oxygen consumption increase shows that the energy is needed for the formation and maintenance of blastocoel [1, 2, 3, 5].
Increased metabolism of the blastocyst occurs due to the increased release of blastomere to 150–200 cells with the formation and maintenance of blastocoel through the activity of Na+/K+ ATPase pump which produces energy. Energy is needed for the degradation of the zona pellucida with protease enzyme. Pyruvate as a source of energy reserves other than carbohydrates also functions as an antioxidant [1, 2, 3, 5].
The human blastocyst uses amino acids as a source of energy in the catabolism process and produces ammonium 30 pmol/hour. The most used amino acid is aspartate, besides consuming arginine, serine, methionine, valine, and leucine [1, 2, 3, 5].
Metabolism of the blastocyst occurs in two different places: in trophectoderm (TE) cells where glucose consumption occurs and half is converted to lactate, whereas glycolysis process occurs in inner cell mass (ICM) (Figures 1, 2, 3) [1, 2, 3, 5].
3. Morphology of the blastocyst
In in vitro fertilization (IVF), the blastocyst culture was important to increase the success rate of IVF because of better embryo selection after better genomic activation and endometrial receptivity . The blastocyst comprises two cell types: the inner cell mass (ICM, from which the fetal tissues develop) and the trophectoderm (which will form mostly extraembryonic tissues such as the placenta ). This morphological differentiation was thought to represent the developmental capability of the blastocyst [6, 7].
3.1 Degree of expansion
The fluid accumulation presence between cells at the morulae stage is the phase that determines embryonic development. The accumulated fluid will form blastocoel gradually which usually occurs on day 4 and/or on the beginning of day 5 human embryo stage which marks the development of new embryos known as the blastocyst stage. An increase in fluid volume and the number of cells in the blastocyst causes an enhancement in the size cavity of the blastocyst and its cavity with depletion of the zona pellucida (ZP) . The number of cells that comprise a blastocyst can vary considerably as shown in one study to range between 24 and 322 cells, which is often reflected in the blastocyst’s morphology .
The stages of blastocyst embryo development are divided into four grades. A grade of 1 is given to the embryo with blastocoel cavity less than 50% of the embryo volume. A grade of 2 is given to the embryo with blastocoel cavity as much as 50% of the embryo volume or even more than that. A grade of 3 was given to the embryo that had a blastocoel cavity which had fulfilled that all embryos and zona pellucida (ZP) appeared to be thinner than embryo on day 3. A grade of 4 is given to the embryo that has successfully hatched from ZP [6, 9].
3.2 ICM morphology
A collection of cells located within the blastocoel in one pole of the blastocyst cavity is called ICM. ICM will develop into fetal tissue. ICM consists of tightly packed cells and loosely bound cells that cause the size of the ICM very large and/or small morphologically . The morphological form of ICM is assessed based on how much the cell compaction is until there is no cell clot at all. A grade of 1 is given to ICM with a very large and dense form of cell clots. A grade of 2 is given to ICM with a slightly diffuse cell form. A grade of 3 is given to ICM with very few cells and which does not even form clots. However, the best ICM grade (A) contains tightly packed and many cells; the middle ICM grade (B) is composed of loosely grouped and several cells, and the worst grade (C) describes an ICM that contains very few cells that are loosely bound [6, 9].
3.3 TE morphology
The outer cells of the blastocyst, forming the blastocyst structure itself, are called the trophectoderm (TE) cells. TE cells play a role in the formation of fluid accumulation in the blastocoel which can be a key in ICM determination, but in the early stages of the blastocyst stage, the role of TE cells is unclear. TE cells will develop into extraembryonic tissue such as the placenta. In addition, TE cells are thought to play a role in the implantation process which the TE cells have contributed in the phase of apposition, adhesion, and invasion of the endometrium which can support the implantation of the blastocyst in the uterus. Molecular factors are also produced by TE cells that play a role in the embryo implantation process [6, 7, 8, 9]. The TE cells have traditionally been graded in a similar manner to the ICM, i.e., by their number and cohesiveness according to three different grades (A, B, C). According to blastocyst grading by Gardner and Schoolcraft, the best TE cell grade (A) contains many cells that form a cohesive epithelium; the middle TE category (B) is composed of few cells forming a loose epithelium, and the worst category (C) describes a TE that contains very few large cells that struggle to form a cohesive epithelium. However, other publications have found no relationship between TE grade and viability (Figure 4) [6, 8, 9].
Gardner and Schoolcraft in 1999 introduced the blastocyst grading system which is adopted by the majority of IVF laboratories in the world. In the blastocyst grading system, they classified the degree of blastocyst into three category, i.e., degree of expansion, inner cell mass (ICM) quality, and the trophectoderm (TE) cell quality [6, 10].
Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology states that a good embryo on day 5 which is examined at 116 ± 2 hours must be in the form of blastocyst .
Embryo, according to the Istanbul consensus, is given a grade based on three things; the first thing is the embryo development stage, the second is ICM, and the third is TE. So that the order of the fifth day embryo assessment is based on the stages of development, then based on ICM morphology, and the last is based on TE. The following is a presentation of the fifth day embryo according to the Istanbul consensus (Figures 5, 6, 7, 8, 9
|Expansion grade||Blastocyst development and stage status|
|1||Early blastocyst—Blastocoel cavity less than half the volume of the embryo|
|2||Blastocyst—Blastocoel cavity more than half the volume of the embryo|
|3||Full blastocyst—Blastocoel completely filling the embryo|
|4||Expanded blastocyst—Blastocoel volume is now larger than that of early embryo and zona is thinner|
|5||Hatching out of the shell|
|6||Hatched out of the shell|
|A||Tightly packed and many cells|
|B||Loosely grouped and several cells|
|C||Very few cells|
|A||Many cells forming a cohesive epithelium|
|B||Few cells forming a loose epithelium|
|C||Very few large cells|
4. Gene expression of human preimplantation embryo
The human embryo preimplantation development is characterized by reprogramming and programming that encompasses fusion of the egg and sperm pronuclei, epigenetic reprogramming, an extensive wave of degradation of maternal transcripts, and activation of the nascent human embryonic genome [11, 12].
There are 1909 genes expressed in only oocytes (maternal genome) and 3122 genes expressed in only blastocyst (embryonic genome). The main difference in observed profile expression between oocytes and embryos is reflected in blastocyst and oocyte specific gene expression analysis. Specific oocyte and blastocyst genes are separated in groups by expression levels. There are 270 specific oocyte genes and 308 blastocyst-specific genes that show high levels of expression. In the panther pathway analysis of high expression genes, the MII oocyte pathway is Wnt signaling pathway, where blastocyst-specific genes are expressed according to integrin signaling pathway, cytoskeletal regulation. The scarcity of the materials, however, both in size (10.1 mm diameter) and in quantity (only a few to tens of oocytes from each ovulation), have been almost the molecular analysis of preimplantation embryos [11, 12, 13].
Some interesting patterns in embryo preimplantation based on transcriptional genome-wide analysis include: (1) several genes that experience up- or downregulation during human oocyte maturation from immature germinal vesicle oocyte to the oocyte metaphase II stage; (2) partially expressed transcripts of the MII oocytes will be partially downregulated or degraded during the development to the 4-cell stage; (3) many genes are upregulated after the 4-cell stage, which reflects the main wave Embryonic Genome Activation (EGA); (4) genes involved in lineage commitment are regulated in the development of preimplantation; and (5) many expressed genes dynamically encode transcription factors, epigenetic modifying factors, and chromatin remodeling [12, 13, 14, 15, 16].
Human genome activation begins in the 4- and 8-cell stages or even in the early 2-cell stage. Data suggest that TE or ICM cell lineage-associated genes are expressed in human embryos later than in mice at around early blastocyst stage, but it is still unclear. Human embryos can be cultured in vitro for 7–8 days post-fertilization. Genes unique in the blastocysts included annexins A2 and A3 (ANXA2, ANXA3), gap junction protein alpha 1 (GJPA1), guanosine triphosphate-binding protein 4 (GTPBP4), and adenosine triphosphatase H.–transporting, lysosomal accessory protein 1 (ATP6AP1). The blastocyst-specific genes were associated with oxidative phosphorylation, glycolysis, and sterol metabolism and were rich in RNA-binding proteins, methyltransferases, gap junction proteins, and intermediate filaments. Oxidative phosphorylation and glycolysis processes control ATP generation during pre-compaction and cavitation stages, respectively. Highly expressed blastocyst genes were involved in the Rho GTPase, control pathway that regulates cytoskeletal changes occurring during cell growth and development; the PDGF pathway, which plays a critical role in cellular proliferation and metabolism, and the integrin signaling pathway are also important in actin reorganization [12, 13, 14, 15, 16, 17, 18, 19].
Studies on gene expression during the preimplantation period have identified transcription factors from housekeeping genes, transcription and growth factor genes, sex-determining genes, tissues specifics, novel genes, and genes of unknown functions [12, 13].
4.1 Housekeeping gene
Housekeeping gene is a gene that plays a role in regulating basal cell function which is important in cell maintenance and also has a specific role in tissues or organisms. Therefore, housekeeping gene is estimated to be expressed in all cells of organism normally, including tissue, external signal, cell cycle, or cell development stage [12, 13, 20].
Beta-actin, keratin-18, ubiquitous cytoskeletal elements, cell adhesion molecules, and alpha tubulin have been detected, as well as such housekeeping genes as hypoxanthine phosphoribosyl transferase (HPRT), adenosine phosphoribosyl transferase (APRT), glucose-6-phosphate dehydrogenase, hexokinase I, and adenosine deaminase. Overall, out of the 536 housekeeping genes investigated, 427 were detected in the oocyte and 452 in the blastocyst [12, 13, 20].
4.2 Transcription and growth factor genes
Transcription regulators, growth factors, proto-oncogenes cycle gene cells, and receptors are several genes that expressed during the preimplantation period, including CD44, a cell surface glycoprotein that can play a role in implantation; OCT 4 and OCT 6, transcriptional regulators; cyclin B1, a cell cycle gene; colony stimulating factor 1 receptor, c-fms; tumor necrosis factor and its receptors; interleukin-1 type I receptor (IL-1R tI); growth factors such as insulin and their receptors; epidermal growth factor receptor (EGF-R), epidermal growth factor (EGF), and transformation of growth factor-alpha (TGF-α) [12, 13, 17, 18, 19].
4.3 Tissue-specific genes, novel genes, and genes of unknown function
A major histocompatibility complex molecule was detected in preimplantation human embryos and implicated tissue-specific genes as globin and interleukin-10 and also human transposable element, LINE-1, and known expressed sequence tags (ESTs) in the GenBank and dbEST databases. Of the 46 peptide hormone genes investigated, 13 were detected in the human blastocysts (SPAG9, TMSB10, OXT, POMC, PPY, SCT, LHB, TRH, PRLH, GNRH2, GIP, CCK, and GPHB5) of which four, namely, SPAG9, TMSB10, OXT, and POMC, showed high expression levels. Thirty-two out of the 162 investigated genes coding for human HRs were detected in the human blastocysts, of which NPM1, ATP6AP2, LEPROTL1, and HTR1D showed high expression levels [12, 13, 15, 16, 17, 21].
Aneuploidy is common in humans and is the leading cause of all human birth defects as well as miscarriage; errors can arise in meiosis during generation of the oocyte and sperm and in the mitotic divisions of the nascent embryo. A recent study used array-based technology to examine the genome-wide copy number of distinct loci in the cleavage stage human embryos. This study identified several types of chromosomal abnormalities that occurred in human embryos and observed that mosaicism for whole chromosomes (aneuploidies) in one or more blastomeres occurred in more than 80% of embryos [11, 12, 17, 22].
Human preimplantation embryos will become an integral and essential part of such endeavors by setting the genetic foundation that determines the course of human development. It is characterized by reprogramming and programming that encompasses fusion of the egg and sperm pronuclei, epigenetic reprogramming, an extensive wave of degradation of maternal transcripts, and activation of the nascent human embryonic genome. The main objective of blastocyst culture was to increase the success rate of in vitro fertilization (IVF) because of better embryo selection after endometrial synchronicity and/or better genomic activation. Metabolism of the blastocyst occurs in two different places: in trophectoderm cells where glucose consumption occurs and half is converted to lactate, whereas glycolysis occurs in ICM. Morphology of the blastocyst depends on the degree of expansion and ICM and TE morphology. This morphological differentiation was thought to represent the developmental capability of the blastocyst. Gene expression during the preimplantation period has identified transcription factors from housekeeping genes, transcription and growth factor genes, sex-determining genes, tissues specifics, novel genes, and genes of unknown functions. Genes unique in human blastocysts included annexins A2 and A3 (ANXA2, ANXA3), gap junction protein alpha 1 (GJPA1), guanosine triphosphate-binding protein 4 (GTPBP4), and adenosine triphosphatase H.–transporting, lysosomal accessory protein 1 (ATP6AP1). The blastocyst-specific genes were associated with oxidative phosphorylation, glycolysis, and sterol metabolism.
The authors thank all of team Halim fertility center for their help and support to this book.
Conflict of interest
There is no conflict of interests in this manuscript.
Gardner DK, Harvey AJ. Blastocyst metabolism. Reproduction, Fertility, and Development. 2015; 27:638-654. DOI: 10.1071/RD14421
Gardner DK, Montag M. Human embryo development and assessment of viability. In: Gardner DK, Simon C, editors. Handbook of In Vitro Fertilization. 4th ed. Boca Raton: CRC Press; 2017. pp. 181-204
Gardner DK, Wale PL. Analysis of metabolism to select viable human embryo to transfer. Fertility and Sterility. 2013; 99:1062-1072. DOI: 10.1016/j.fertnstert.2012.12.004
Jones GM, Trounson AO, Vella PJ, Thouas GA, et al. Glucose metabolism of human morula and blastocyst-stage embryos and its relationship to viability after transfer. Reproductive BioMedicine Online. 2001; 3(2):124-132
Gardner DK, Wale PL, Collins R, Lane M. Glucose consumption of single post-compaction human embryos is predictive of embryo sex and live birth outcome. Human Reproduction. 2011; 26:1981-1986. DOI: 10.1093/HUMREP/DER143
Handarson T, Landuyt LV, Jones G. The blastocyst. Human Reproduction. 2012; 27(S I):i72-i91. DOI: 10.1093/humrep/des230
Carson DD, Bagchi I, De SK, Enders AC. Embryo implantation. Developmental Biology. 2000; 223:217-237. DOI: 10.1006/dbio.2000.9767
Hardarson T, Caisander C, Sjo¨gren A, Hanson C, Hamberger L, Lundin K. A morphological and chromosomal study of blastocysts developing from morphologically suboptimal human preembryos compared to control blastocysts. Human Reproduction. 2003; 18:399-407
Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology. The Istanbul consensus workshop on embryo assessment: Proceedings of an expert meeting. Human Reproduction. 2011; 26:1270-1283
Gardner DK, Schoolcraft WB. In vitro culture of human blastocysts. In: Jansen R, Mortimer D, editors. Toward Reproductive Certainty: Fertility and Genetics Beyond. UK: Parthenon Publishing London; 1999. pp. 378-388
Niakan KK, Han J, Pedersen R, Simon C, Pera AR. Human pre-implantation embryo development. Development. 2012; 139:829-841. DOI: 10.1242/dev.060426
Pergament E, Fiddler M. The expression of genes in human preimplantation embryos. Prenatal Diagnosis. 1998; 18:1366-1373
Kakourou G, Jaroudi S, Tulay P, et al. Investigation of gene expression profiles before and after embryonic genome activation and assessment offunctional pathways at the human metaphase II oocyte and blastocyst stage. Fertility and Sterility. 2013; 99(1):803-814. DOI: 10.1016/j.fertnstert.2012.10.036
Latham KE, Schultz RM. Embryonic genome activation. Frontiers in Bioscience. 2001; 6:d748-d759
Hamatani T, Daikoku T, Wang H, Matsumoto H, Carter MG, Ko MS, et al. Global gene expression analysis identifies molecular pathways distinguishing blastocyst dormancy and activation. Proceedings of the National Academy of Sciences of the United States of America. 2004; 101:10326-10331
Hamatani T, Ko M, Yamada M, Kuji N, Mizusawa Y, Shoji M, et al. Global gene expression profiling of preimplantation embryos. Human Cell. 2006; 19:98-117
Vanneste E, Voet T, Caignec CL, Ampe M, Konings P, Melotte C, et al. Chromosome instability is common in human cleavage-stage embryos. Nature Medicine. 2009; 15:577-583
Zhang P, Zucchelli M, Bruce S, Hambiliki F, Stavreus-Evers A, Levkov L, et al. Transcriptome profiling of human preimplantation development. PLoS One. 2009; 4:e7844
Dobson AT, Raja R, Abeyta MJ, Taylor T, Shen S, Haqq C, et al. The unique transcriptome through day 3 of human preimplantation development. Human Molecular Genetics. 2004; 13:1461-1470
Eisenberg E, Levanon EY. Human housekeeping genes, revisited. Trends in Genetics. 2013; 1062:1-6. DOI: 10.1016/j.tig.2013.05.010
Jurisicova A, Casper RF, MacLusky NJ, Librach CL. HLA-G expression during preimplantation human embryo development. Proceedings of the National Academy of Sciences of the United States of America. 1996b; 93:161-165
Munné S, Lee A, Rosenwaks Z, Grifo J, Cohen J. Diagnosis of major chromosome aneuploidies in human preimplantation embryos. Human Reproduction. 1993; 8:2185-2191